A review of evidence for safe abortion care
- PMID:23261233
- DOI: 10.1016/j.contraception.2012.10.027
A review of evidence for safe abortion care
Abstract
Background: The provision of safe abortion services to women who need them has the potential to drastically reduce or eliminate maternal deaths due to unsafe abortion. The World Health Organization recently updated its evidence-based guidance for safe and effective clinical practices using data from systematic reviews of the literature.
Materials and methods: Systematic reviews pertaining to the evidence for safe abortion services, from pre-abortion care, medical and surgical methods of abortion and post-abortion care were evaluated for relevant outcomes, primarily those relating to safety, effectiveness and women's preference.
Results: Sixteen systematic reviews were identified and evaluated. The available evidence does not support the use of pre-abortion ultrasound to increase safety. Routine use of cervical preparation with osmotic dilators, mifepristone or misoprostol after 14 weeks gestation reduces complications; at early gestational ages, surgical abortions have very few complications. Prophylactic antibiotics result in lower rates of post-surgical abortion infection. Pain medication such as non-steroidal anti-inflammatories should be offered to women undergoing abortion procedures; acetaminophen, however, is not effective in reducing pain. Women who are eligible should be offered a choice between surgical (vacuum aspiration or dilation and evacuation) and medical methods (mifepristone and misoprostol) of abortion when possible. Modern methods of contraception can be safely initiated immediately following abortion procedures.
Conclusions: Evidence-based guidelines assist health care providers and policymakers to utilize the best data available to provide safe abortion care and prevent the millions of deaths and disabilities that result from unsafe abortion.
Keywords: Abortion care; Evidence-based guidelines; Medical abortion; Surgical abortion.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
- Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management.Gemzell-Danielsson K, Lalitkumar S.Gemzell-Danielsson K, et al.Reprod Health Matters. 2008 May;16(31 Suppl):162-72. doi: 10.1016/S0968-8080(08)31371-8.Reprod Health Matters. 2008.PMID:18772097Review.
- Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.Kopp Kallner H, Fiala C, Stephansson O, Gemzell-Danielsson K.Kopp Kallner H, et al.Hum Reprod. 2010 May;25(5):1153-7. doi: 10.1093/humrep/deq037. Epub 2010 Feb 19.Hum Reprod. 2010.PMID:20172871
- Randomised preference trial of medical versus surgical termination of pregnancy less than 14 weeks' gestation (TOPS).Robson SC, Kelly T, Howel D, Deverill M, Hewison J, Lie ML, Stamp E, Armstrong N, May CR.Robson SC, et al.Health Technol Assess. 2009 Nov;13(53):1-124, iii-iv. doi: 10.3310/hta13530.Health Technol Assess. 2009.PMID:19906334Clinical Trial.
- Cervical preparation for second trimester dilation and evacuation.Newmann SJ, Dalve-Endres A, Diedrich JT, Steinauer JE, Meckstroth K, Drey EA.Newmann SJ, et al.Cochrane Database Syst Rev. 2010 Aug 4;(8):CD007310. doi: 10.1002/14651858.CD007310.pub2.Cochrane Database Syst Rev. 2010.PMID:20687085Review.
- [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].Faucher P, Baunot N, Madelenat P.Faucher P, et al.Gynecol Obstet Fertil. 2005 Apr;33(4):220-7. doi: 10.1016/j.gyobfe.2005.02.021. Epub 2005 Mar 22.Gynecol Obstet Fertil. 2005.PMID:15894206Clinical Trial.French.
Cited by
- A Retrospective Cost-Effectiveness Analysis of Mifepristone-Misoprostol Medical Abortions in the First Year at the Regina General Hospital.Hunter C, Jensen J, Imeah B, McCarron M, Clark M.Hunter C, et al.J Obstet Gynaecol Can. 2021 Feb;43(2):211-218. doi: 10.1016/j.jogc.2020.08.008. Epub 2020 Aug 25.J Obstet Gynaecol Can. 2021.PMID:33153943Free PMC article.
- Abortion-related care and the role of the midwife: a global perspective.Fullerton J, Butler MM, Aman C, Reid T, Dowler M.Fullerton J, et al.Int J Womens Health. 2018 Nov 23;10:751-762. doi: 10.2147/IJWH.S178601. eCollection 2018.Int J Womens Health. 2018.PMID:30538585Free PMC article.
- Could implementation of mifepristone address Canada's urban-rural abortion access disparity: a mixed-methods implementation study protocol.Norman WV, Munro S, Brooks M, Devane C, Guilbert E, Renner R, Kendall T, Soon JA, Waddington A, Wagner MS, Dunn S.Norman WV, et al.BMJ Open. 2019 Apr 20;9(4):e028443. doi: 10.1136/bmjopen-2018-028443.BMJ Open. 2019.PMID:31005943Free PMC article.
- Factors Associated with Abortion in Women of Reproductive Age.Santos AP, Coelho Ede A, Gusmão ME, Silva DO, Marques PF, Almeida MS.Santos AP, et al.Rev Bras Ginecol Obstet. 2016 Jun;38(6):273-9. doi: 10.1055/s-0036-1584940. Epub 2016 Jul 11.Rev Bras Ginecol Obstet. 2016.PMID:27399921Free PMC article.
- COMPARISON BETWEEN SUBLINGUAL AND VAGINAL ROUTE OF MISOPROSTOL IN MANAGEMENT OF FIRST TRIMESTER MISCARRIAGE MISSING.Dehbashi Z, Moosazadeh M, Afshari M.Dehbashi Z, et al.Mater Sociomed. 2016 Jul 24;28(4):271-273. doi: 10.5455/msm.2016.28.271-273.Mater Sociomed. 2016.PMID:27698600Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical